liverpool school of tropical medicine
liverpool school of tropical medicine Company Information
Company Number
00083405
Website
http://www.lstmed.ac.ukRegistered Address
pembroke place, liverpool 3, l3 5qa, L3 9HF
Industry
Research and experimental development on social sciences and humanities
Post-graduate level higher education
Telephone
01517053100
Next Accounts Due
April 2025
Group Structure
View All
Shareholders
-0%
liverpool school of tropical medicine Estimated Valuation
Pomanda estimates the enterprise value of LIVERPOOL SCHOOL OF TROPICAL MEDICINE at £238.5m based on a Turnover of £154.8m and 1.54x industry multiple (adjusted for size and gross margin).
liverpool school of tropical medicine Estimated Valuation
Pomanda estimates the enterprise value of LIVERPOOL SCHOOL OF TROPICAL MEDICINE at £84.4m based on an EBITDA of £10.6m and a 7.99x industry multiple (adjusted for size and gross margin).
liverpool school of tropical medicine Estimated Valuation
Pomanda estimates the enterprise value of LIVERPOOL SCHOOL OF TROPICAL MEDICINE at £90.2m based on Net Assets of £55.7m and 1.62x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Liverpool School Of Tropical Medicine Overview
Liverpool School Of Tropical Medicine is a live company located in l3 5qa, L3 9HF with a Companies House number of 00083405. It operates in the research and experimental development on social sciences and humanities sector, SIC Code 72200. Founded in January 1905, it's largest shareholder is unknown. Liverpool School Of Tropical Medicine is a mature, mega sized company, Pomanda has estimated its turnover at £154.8m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Liverpool School Of Tropical Medicine Health Check
Pomanda's financial health check has awarded Liverpool School Of Tropical Medicine a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
5 Weak
Size
annual sales of £154.8m, make it larger than the average company (£839.9k)
£154.8m - Liverpool School Of Tropical Medicine
£839.9k - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (6%)
-12% - Liverpool School Of Tropical Medicine
6% - Industry AVG
Production
with a gross margin of 67.5%, this company has a comparable cost of product (67.5%)
67.5% - Liverpool School Of Tropical Medicine
67.5% - Industry AVG
Profitability
an operating margin of 5.1% make it more profitable than the average company (2.8%)
5.1% - Liverpool School Of Tropical Medicine
2.8% - Industry AVG
Employees
with 805 employees, this is above the industry average (14)
805 - Liverpool School Of Tropical Medicine
14 - Industry AVG
Pay Structure
on an average salary of £50.3k, the company has an equivalent pay structure (£43k)
£50.3k - Liverpool School Of Tropical Medicine
£43k - Industry AVG
Efficiency
resulting in sales per employee of £192.3k, this is more efficient (£89.8k)
£192.3k - Liverpool School Of Tropical Medicine
£89.8k - Industry AVG
Debtor Days
it gets paid by customers after 51 days, this is later than average (35 days)
51 days - Liverpool School Of Tropical Medicine
35 days - Industry AVG
Creditor Days
its suppliers are paid after 312 days, this is slower than average (25 days)
312 days - Liverpool School Of Tropical Medicine
25 days - Industry AVG
Stock Days
it holds stock equivalent to 27 days, this is more than average (18 days)
27 days - Liverpool School Of Tropical Medicine
18 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 32 weeks, this is less cash available to meet short term requirements (73 weeks)
32 weeks - Liverpool School Of Tropical Medicine
73 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 69.4%, this is a higher level of debt than the average (33.7%)
69.4% - Liverpool School Of Tropical Medicine
33.7% - Industry AVG
LIVERPOOL SCHOOL OF TROPICAL MEDICINE financials
Liverpool School Of Tropical Medicine's latest turnover from July 2023 is £154.8 million and the company has net assets of £55.7 million. According to their latest financial statements, Liverpool School Of Tropical Medicine has 805 employees and maintains cash reserves of £40.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 154,796,000 | 196,652,000 | 193,438,000 | 228,069,000 | 242,674,000 | 232,397,000 | 209,185,000 | 78,358,000 | 76,533,000 | 65,390,000 | 59,994,000 | 57,716,000 | 53,524,000 | 52,525,000 | 40,205,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | 7,898,000 | -6,688,000 | 4,791,000 | 11,977,000 | |||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 37,000 | 156,000 | 164,000 | 77,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 7,774,000 | -7,467,000 | 6,648,000 | 9,019,000 | -12,242,000 | 4,948,000 | 1,467,000 | 3,198,000 | -80,000 | 2,241,000 | 2,191,000 | 2,079,000 | 575,000 | 1,738,000 | 485,000 |
| Tax | -4,000 | 0 | -39,000 | 24,000 | 0 | 0 | 0 | -2,000 | -1,000 | -6,000 | -2,000 | -3,000 | 0 | -5,000 | 6,000 |
| Profit After Tax | 7,770,000 | -7,467,000 | 6,609,000 | 9,043,000 | -12,242,000 | 4,948,000 | 1,467,000 | 3,196,000 | -81,000 | 2,235,000 | 2,189,000 | 2,076,000 | 575,000 | 1,733,000 | 491,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 7,770,000 | -7,467,000 | 6,609,000 | 9,043,000 | -12,242,000 | 4,948,000 | 1,467,000 | 3,196,000 | -81,000 | 2,235,000 | 2,189,000 | 2,076,000 | 575,000 | 1,733,000 | 491,000 |
| Employee Costs | 40,497,000 | 38,796,000 | 37,622,000 | 38,560,000 | 50,468,000 | 30,914,000 | 26,786,000 | 24,120,000 | 25,688,000 | 19,622,000 | 17,981,000 | 17,151,000 | 15,498,000 | 14,787,000 | 13,256,000 |
| Number Of Employees | 805 | 714 | 701 | 650 | 667 | 634 | 508 | 490 | 455 | 408 | 355 | 329 | 317 | 298 | 274 |
| EBITDA* | 10,554,000 | -4,502,000 | 6,832,000 | 11,977,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 68,764,000 | 62,310,000 | 59,094,000 | 58,691,000 | 59,855,000 | 60,823,000 | 47,244,000 | 46,802,000 | 47,079,000 | 42,502,000 | 39,883,000 | 36,488,000 | 37,101,000 | 33,036,000 | 32,067,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,895,000 | 12,511,000 | 13,390,000 | 13,597,000 | 6,561,000 | 5,899,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 68,764,000 | 62,310,000 | 59,094,000 | 58,691,000 | 59,855,000 | 60,823,000 | 47,244,000 | 46,802,000 | 47,079,000 | 55,397,000 | 52,394,000 | 49,878,000 | 50,698,000 | 39,597,000 | 37,966,000 |
| Stock & work in progress | 3,785,000 | 159,000 | 81,000 | 94,000 | 96,000 | 106,000 | 94,000 | 82,000 | 64,000 | 57,000 | 66,000 | 60,000 | 112,000 | 67,000 | 112,000 |
| Trade Debtors | 21,776,000 | 19,398,000 | 14,771,000 | 1,419,000 | 1,641,000 | 940,000 | 666,000 | 606,000 | 781,000 | 457,000 | 733,000 | 770,000 | 902,000 | 1,424,000 | 569,000 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11,159,000 | 507,000 | 431,000 | 312,000 | 962,000 | 211,000 |
| Misc Debtors | 1,776,000 | 2,483,000 | 2,464,000 | 22,368,000 | 24,441,000 | 27,844,000 | 15,740,000 | 19,784,000 | 12,019,000 | 1,357,000 | 9,960,000 | 6,999,000 | 5,921,000 | 4,280,000 | 5,934,000 |
| Cash | 40,081,000 | 44,038,000 | 52,154,000 | 46,250,000 | 53,308,000 | 34,275,000 | 50,481,000 | 50,966,000 | 26,233,000 | 19,120,000 | 20,203,000 | 11,670,000 | 10,831,000 | 22,186,000 | 20,770,000 |
| misc current assets | 45,818,000 | 43,602,000 | 47,848,000 | 31,100,000 | 40,585,000 | 40,361,000 | 31,520,000 | 25,740,000 | 24,519,000 | 12,297,000 | 12,032,000 | 11,491,000 | 11,146,000 | 4,688,000 | 2,984,000 |
| total current assets | 113,236,000 | 109,680,000 | 117,318,000 | 101,231,000 | 120,071,000 | 103,526,000 | 98,501,000 | 97,178,000 | 63,616,000 | 44,447,000 | 43,501,000 | 31,421,000 | 29,224,000 | 33,607,000 | 30,580,000 |
| total assets | 182,000,000 | 171,990,000 | 176,412,000 | 159,922,000 | 179,926,000 | 164,349,000 | 145,745,000 | 143,980,000 | 110,695,000 | 99,844,000 | 95,895,000 | 81,299,000 | 79,922,000 | 73,204,000 | 68,546,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35,000 | 0 | 207,000 | 832,000 | 556,000 | 472,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100,000 | 0 | 0 | 0 | 0 |
| Trade Creditors | 43,104,000 | 41,787,000 | 882,000 | 287,000 | 1,337,000 | 1,230,000 | 1,396,000 | 685,000 | 1,280,000 | 2,625,000 | 458,000 | 498,000 | 529,000 | 432,000 | 628,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 4,937,000 | 1,168,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 453,000 | 426,000 | 412,000 | 375,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 15,858,000 | 16,394,000 | 71,907,000 | 65,220,000 | 81,447,000 | 70,085,000 | 68,078,000 | 73,644,000 | 43,287,000 | 35,658,000 | 38,245,000 | 27,681,000 | 27,481,000 | 28,326,000 | 28,045,000 |
| total current liabilities | 63,899,000 | 59,349,000 | 73,242,000 | 65,933,000 | 83,196,000 | 71,690,000 | 69,474,000 | 74,329,000 | 44,567,000 | 38,318,000 | 38,803,000 | 28,386,000 | 28,842,000 | 29,314,000 | 29,145,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 8,608,000 | 9,033,000 | 9,368,000 | 9,794,000 | 10,215,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 38,127,000 | 30,846,000 | 25,911,000 | 24,928,000 | 0 | 0 | 0 | 23,384,000 | 23,098,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 4,233,000 | 3,941,000 | 3,697,000 | 1,827,000 | 1,173,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 62,425,000 | 64,778,000 | 47,847,000 | 45,381,000 | 32,816,000 | 16,838,000 | 6,623,000 | 29,238,000 | 29,196,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 126,324,000 | 124,127,000 | 121,089,000 | 111,314,000 | 116,012,000 | 88,528,000 | 76,097,000 | 103,567,000 | 73,763,000 | 38,318,000 | 38,803,000 | 28,386,000 | 28,842,000 | 29,314,000 | 29,145,000 |
| net assets | 55,676,000 | 47,863,000 | 55,323,000 | 48,608,000 | 63,914,000 | 75,821,000 | 69,648,000 | 40,413,000 | 36,932,000 | 61,526,000 | 57,092,000 | 52,913,000 | 51,080,000 | 43,890,000 | 39,401,000 |
| total shareholders funds | 55,676,000 | 47,863,000 | 55,323,000 | 48,608,000 | 63,914,000 | 75,821,000 | 69,648,000 | 40,413,000 | 36,932,000 | 61,526,000 | 57,092,000 | 52,913,000 | 51,080,000 | 43,890,000 | 39,401,000 |
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 7,898,000 | -6,688,000 | 4,791,000 | 11,977,000 | |||||||||||
| Depreciation | 2,656,000 | 2,186,000 | 2,041,000 | 0 | 0 | 2,069,000 | 1,572,000 | 1,524,000 | 1,110,000 | 1,019,000 | 1,967,000 | 1,120,000 | 1,080,000 | 892,000 | 817,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -4,000 | 0 | -39,000 | 24,000 | 0 | 0 | 0 | -2,000 | -1,000 | -6,000 | -2,000 | -3,000 | 0 | -5,000 | 6,000 |
| Stock | 3,626,000 | 78,000 | -13,000 | -2,000 | -10,000 | 12,000 | 12,000 | 18,000 | 7,000 | -9,000 | 6,000 | -52,000 | 45,000 | -45,000 | 112,000 |
| Debtors | 1,671,000 | 4,646,000 | -6,552,000 | -2,295,000 | -2,702,000 | 12,378,000 | -3,984,000 | 7,590,000 | -173,000 | 1,773,000 | 3,000,000 | 1,065,000 | 469,000 | -48,000 | 6,714,000 |
| Creditors | 1,317,000 | 40,905,000 | 595,000 | -1,050,000 | 107,000 | -166,000 | 711,000 | -595,000 | -1,345,000 | 2,167,000 | -40,000 | -31,000 | 97,000 | -196,000 | 628,000 |
| Accruals and Deferred Income | 6,745,000 | -50,578,000 | 7,670,000 | 8,701,000 | 11,362,000 | 2,007,000 | -28,950,000 | 30,643,000 | 30,727,000 | -2,587,000 | 10,564,000 | 200,000 | -845,000 | 281,000 | 28,045,000 |
| Deferred Taxes & Provisions | 292,000 | 244,000 | 1,870,000 | 654,000 | 1,173,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 13,607,000 | -18,655,000 | 23,493,000 | 22,603,000 | |||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 3,263,000 | -20,047,000 | -3,872,000 | -351,000 | -2,734,000 | -1,321,000 | -1,792,000 | -3,069,000 | -8,651,000 | -430,000 | -2,558,000 |
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12,895,000 | 384,000 | -879,000 | -207,000 | 7,036,000 | 662,000 | 5,899,000 |
| cash flow from investments | 0 | 0 | 0 | 0 | 3,263,000 | -20,047,000 | -3,872,000 | -351,000 | 10,161,000 | -1,705,000 | -913,000 | -2,862,000 | -15,687,000 | -1,092,000 | -8,457,000 |
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100,000 | 100,000 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 3,769,000 | 1,168,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | -8,608,000 | -878,000 | -308,000 | -412,000 | -384,000 | 10,590,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | -37,000 | -156,000 | -164,000 | -77,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | -4,796,000 | 297,000 | -202,000 | -24,761,000 | -49,000 | 11,778,000 | 27,612,000 | 121,000 | -24,590,000 | 2,099,000 | 2,090,000 | -243,000 | 6,615,000 | 2,756,000 | 38,910,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -3,957,000 | -8,116,000 | 5,904,000 | -7,058,000 | 19,033,000 | -16,206,000 | -485,000 | 24,733,000 | 7,113,000 | -1,083,000 | 8,533,000 | 839,000 | -11,355,000 | 1,416,000 | 20,770,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -35,000 | 35,000 | -207,000 | -625,000 | 276,000 | 84,000 | 472,000 |
| change in cash | -3,957,000 | -8,116,000 | 5,904,000 | -7,058,000 | 19,033,000 | -16,206,000 | -485,000 | 24,733,000 | 7,148,000 | -1,118,000 | 8,740,000 | 1,464,000 | -11,631,000 | 1,332,000 | 20,298,000 |
liverpool school of tropical medicine Credit Report and Business Information
Liverpool School Of Tropical Medicine Competitor Analysis
Perform a competitor analysis for liverpool school of tropical medicine by selecting its closest rivals and benchmarking them against 12 key performance metrics.
liverpool school of tropical medicine Ownership
LIVERPOOL SCHOOL OF TROPICAL MEDICINE group structure
Liverpool School Of Tropical Medicine has 3 subsidiary companies.
Ultimate parent company
LIVERPOOL SCHOOL OF TROPICAL MEDICINE
00083405
3 subsidiaries
liverpool school of tropical medicine directors
Liverpool School Of Tropical Medicine currently has 15 directors. The longest serving directors include Mr Mark Allanson (Mar 2016) and Mrs Susan Russell (Aug 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mark Allanson | England | 63 years | Mar 2016 | - | Director |
| Mrs Susan Russell | England | 63 years | Aug 2016 | - | Director |
| Mr John O'Brien | England | 65 years | Mar 2017 | - | Director |
| Professor David Lalloo | 63 years | Jan 2019 | - | Director | |
| Mr Andrew Wright | 66 years | Mar 2019 | - | Director | |
| Mrs Joanne Dodd | 50 years | Aug 2019 | - | Director | |
| Dr Nyovani Madise | England | 63 years | Aug 2019 | - | Director |
| Mr James McKenna | 69 years | Nov 2020 | - | Director | |
| Mr James McKenna | 69 years | Nov 2020 | - | Director | |
| Dr Helen Savage | 35 years | Nov 2021 | - | Director |
P&L
July 2023turnover
154.8m
-21%
operating profit
7.9m
-218%
gross margin
67.5%
+13.19%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
55.7m
+0.16%
total assets
182m
+0.06%
cash
40.1m
-0.09%
net assets
Total assets minus all liabilities
liverpool school of tropical medicine company details
company number
00083405
Type
Private Ltd By Guarantee w/o Share Cap
industry
72200 - Research and experimental development on social sciences and humanities
85422 - Post-graduate level higher education
incorporation date
January 1905
age
119
accounts
Group
ultimate parent company
previous names
incorporated liverpool school of tropical medicine(the) (November 1992)
incorporated
UK
address
pembroke place, liverpool 3, l3 5qa, L3 9HF
last accounts submitted
July 2023
liverpool school of tropical medicine Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to liverpool school of tropical medicine. Currently there are 3 open charges and 2 have been satisfied in the past.
liverpool school of tropical medicine Companies House Filings - See Documents
| date | description | view/download |
|---|
